FDA regulatory news highlights November 2025

5 December 2025

From the press releases of the U.S Food and Drug Administration, Arex Advisor has rounded up a selection of regulatory highlights from November 2025.

FDA Awards Second Batch of National Priority Vouchers

6 November 2025
The FDA has awarded six additional vouchers under its Commissioner’s National Priority Voucher pilot, bringing the total to 15. The programme aims to speed up the review of products that may address critical national priorities, giving developers earlier clarity and potentially faster pathways to market. Read more

FDA launches pilot to speed up clarifications to meeting minutes

19 November 2025
The FDA has introduced a pilot programme offering sponsors a quick “Meeting Minute Clarification Opportunity” after formal meetings. The approach allows sponsors to seek rapid clarification from a single discipline, aiming to streamline communication and reduce delays in understanding regulatory feedback. Read more

How do these changes affect you?

Our experienced specialists are ready to help you navigate the regulatory landscape!

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.